Related Experiment Video
Updated: Jan 26, 2026
06:45
In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
Published on: July 2, 2020
4.8K
Hyperthermia-Triggered Gemcitabine Release from Polymer-Coated Magnetite Nanoparticles
G R Iglesias1, Felisa Reyes-Ortega2, B L Checa Fernandez3
1Department of Applied Physics, Facultad de Ciencias, Campus Fuentenueva, School of Sciences, and MNAT Unit of Excellence, University of Granada, 18071 Granada, Spain. iglesias@ugr.es.
Polymers
|April 11, 2019
Summary
This study presents a novel platform combining magnetic hyperthermia and gemcitabine drug delivery for cancer treatment. The nanostructure effectively releases the drug under alternating magnetic fields, enhancing its potential as an antitumor agent.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Materials Science
Background:
- Developing multifunctional platforms for simultaneous cancer therapy is crucial.
- Magnetic hyperthermia and chemotherapy offer synergistic antitumor effects.
- Biocompatible nanocarriers are essential for targeted drug delivery and therapy.
Purpose of the Study:
- To develop and evaluate a combined magnetic hyperthermia and gemcitabine delivery system.
- To investigate the in vitro performance of the nanostructure for cancer treatment.
- To assess the drug release kinetics under hyperthermia conditions.
Main Methods:
- Fabrication of magnetite nanoparticles coated with biocompatible polymer (polyethylene glycol).
- Surface functionalization with carboxyl groups for electrostatic drug adsorption.
- Characterization of drug loading using electrophoresis and infrared spectroscopy.
- In vitro testing of magnetic hyperthermia and gemcitabine release at different temperatures and magnetic field exposure.
Main Results:
- The nanostructure demonstrated biocompatibility and efficient electrostatic adsorption of gemcitabine hydrochloride.
- Gemcitabine release was temperature-dependent, occurring faster at 43 °C than 37 °C.
- Under alternating magnetic field for hyperthermia at 43 °C, the nanocarrier retained its heating capacity and exhibited accelerated, zeroth-order gemcitabine release.
Conclusions:
- The developed multifunctional platform shows promise for combined magnetic hyperthermia and chemotherapy.
- The accelerated drug release under hyperthermia conditions suggests enhanced therapeutic efficacy.
- This system offers a potential advancement in targeted cancer treatment strategies.
Related Concept Videos
02:34Polymers
40.6K
The word polymer is derived from the Greek words “poly” which means “many” and “mer” which means “parts”. Polymers are long chains of molecules composed of repeating units of smaller molecules, known as monomers. They either occur naturally, such as DNA and proteins, or can be constructed synthetically, like plastics. They have varied structural characteristics, such as linear chains, branched chains, or complex networks, that contribute to the...
40.6K
02:34Polymers
23.2K
23.2K
01:12Clathrin Coated Vesicles
9.2K
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
9.2K
00:59COP Coated Vesicles
17.4K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
17.4K
01:33Coat Assembly and GTPases
4.3K
Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
4.3K
01:32Pinching-off of Coated Vesicles
4.0K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
4.0K